TELA Bio (TELA) Change in Accured Expenses (2018 - 2026)

TELA Bio's Change in Accured Expenses history runs 9 years deep, the most recent figure standing at -$1.5 million for Q1 2026.

• On a quarterly basis, Change in Accured Expenses fell 61.08% year-over-year to -$1.5 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a 62.18% increase from a year earlier, with the FY2025 full-year figure at $1.8 million, up 197.29% from the prior year.
• Change in Accured Expenses slipped to -$1.5 million in Q1 2026 per TELA's latest filing, from $663000.0 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $2.8 million in Q4 2023 and bottomed at -$3.5 million in Q1 2024.
• The 5-year median for Change in Accured Expenses is $663000.0 (2025), against an average of $295823.5.
• Across the five-year window, Change in Accured Expenses sank 130.03% in 2024 and soared 178.74% in 2025, its largest moves.
• Year by year, Change in Accured Expenses stood at $1.6 million in 2022, then surged by 75.25% to $2.8 million in 2023, then sank by 130.03% to -$842000.0 in 2024, then surged by 178.74% to $663000.0 in 2025, then tumbled by 325.94% to -$1.5 million in 2026.
• Per Business Quant, the three latest TELA Change in Accured Expenses figures stand at -$1.5 million (Q1 2026), $663000.0 (Q4 2025), and $633000.0 (Q3 2025).